Indications
Bronchospasm such as asthma or COPD in a critically ill patient. Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock needing vasopressors.
Contraindications
Untreated serious infection, known hypersensitivity. IM route is contraindicated in idiopathic thrombocytopenic purpura (ITP). Traumatic brain injury (high doses).
Adult dose
Bronchospasm (asthma, COPD), critically ill: 2 mg/kg IV or IM, max 125 mg
Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock needing vasopressors: 2 mg/kg IV, max 125 mg. Hydrocortisone is preferred if available
Pediatric dose
Bronchospasm (asthma), critically ill, age 2 and older: 2 mg/kg IV or IM, max 125 mg
Adrenal insufficiency, long-term steroid dependence, or fluid-refractory shock needing vasopressors: 2 mg/kg IV, max 125 mg. Hydrocortisone is preferred if available
Route
IV, IM
Special considerations
For adrenal insufficiency, hydrocortisone is preferred, because it has both glucocorticoid and mineralocorticoid effects. Steroids have no proven benefit in allergic reactions or anaphylaxis. Do not give steroids for bronchiolitis.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Respiratory Distress (Includes Bronchospasm, Pulmonary Edema); Shock; Anaphylaxis and Allergic Reaction; Pediatric Respiratory Distress (Bronchiolitis). Levels from the National EMS Scope of Practice Model (2019).